---
title: Map movement mood and sleep
nct_id: NCT06536348
status: RECRUITING
sponsor: Federal University of Uberlandia
study_type: OBSERVATIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT06536348"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT06536348"
last_fetched: "2026-05-20T14:03:08.558Z"
source: "Parkinson's Pathways (curated)"
---
# Map movement mood and sleep

**Goal (in five words):** Map movement mood and sleep

**Official Title:** PARKINSON BRASIL - Database on Motor and Non-Motor Aspects of Parkinson's Disease in Brazil

**Trial ID:** [NCT06536348](https://clinicaltrials.gov/study/NCT06536348)

## Key Facts

- **Status:** RECRUITING
- **Study Type:** OBSERVATIONAL
- **Sponsor:** Federal University of Uberlandia
- **Target Enrollment:** 958 participants
- **Start Date:** 2025-01-01
- **Completion Date:** 2034-10-01
- **Conditions:** Parkinson Disease

## Summary For Families

The project is building a large Brazilian database to map motor and non-motor features of Parkinson's disease, so doctors and researchers can better track symptoms, find patterns, and improve care and future studies. It does this by collecting clinical assessments and tests, recording movement exam results plus non-motor issues like mood, sleep and thinking, and includes vision screening, without testing any experimental drug or device. Participants need to have central visual acuity of at least 20/40 in each eye or 20/30 in one eye because good vision is required for the tests. The study is open to adults 18 to 120, enrolling people with a neurologist-confirmed PD diagnosis at Hoehn and Yahr stages I to IV and control volunteers without PD or similar neurological diseases, while excluding anyone with other neurological or musculoskeletal problems that would prevent testing.

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 120 Years
- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

* Experimental group: (i) present a neurological diagnosis of Parkinson's disease; (ii) be classified between stages I to IV of the Hoehn \& Yahr Scale; (iii) have central visual acuity equal to or greater than 20/40 (equivalent to 0.50) in each eye or equal to or greater than 20/30 (equivalent to 0.66) in one eye according to the Snellen scale.
* Control group: (i) not having a neurological diagnosis of Parkinson's disease or other neurological disease that resembles PD; (ii) have central visual acuity equal to or greater than 20/40 (equivalent to 0.50) in each eye or equal to or greater than 20/30 (equivalent to 0.66) in one eye according to the Snellen scale.

Exclusion Criteria:

For both groups, individuals who have other neurological or musculoskeletal diseases that interfere with the execution of the tests will be excluded.
```

## Locations (5)

- Laboratório de Análise de Movimento e Processamento de Sinais, Brasília, Federal District, Brazil _(-15.7797, -47.9297)_
  - Clarissa Cardoso dos Santos Couto Paz, PhD — (CONTACT) — clarissacardoso@unb.br
- Centro Universitário Araguaia (UniAraguaia), Goiânia, Goiás, Brazil _(-16.6786, -49.2539)_
  - Tatiana Carilly Oliveira Andrade, PhD — (CONTACT) — tatiana@uniaraguaia.edu.br
- Associação Parkinson Goiás, Goiânia, Goiás, Brazil _(-16.6786, -49.2539)_
  - Adriano Andrade, PhD — (CONTACT) — adriano@ufu.br
- Ambulatório de Doença de Parkinson e Distúrbios do Movimento do Hospital de Clínicas de Uberlândia, Uberlândia, Minas Gerais, Brazil _(-18.9186, -48.2772)_
  - Adriano Andrade, PhD — (CONTACT) — adriano@ufu.br
- Núcleo de Inovação e Avaliação Tecnológica em Saúde / Centre for Innovation and Technology Assessment in Health, Uberlândia, Minas Gerais, Brazil _(-18.9186, -48.2772)_
  - Adriano Andrade, PhD — (CONTACT) — adriano@ufu.br

## Central Contacts

- Adriano Andrade, PhD — (CONTACT) — +55 34 3239-4761 — adriano@ufu.br
- Adriano Andrade, PhD — (CONTACT) — + 34 3239-4761 — adriano@ufu.br

---

*Canonical: https://parkinsonspathways.com/trial/NCT06536348*  
*HTML version: https://parkinsonspathways.com/trial/NCT06536348*  
*Source data: https://clinicaltrials.gov/study/NCT06536348*